Head-to-head · WeighScore
Chronos Body Health & Wellness vs Wisp
The verdict
Wisp takes it — 75/100 to 58.4/100.
Wisp grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Chronos Body Health & Wellness | Wisp |
|---|---|---|
| WeighScore | 58.4/100 | 75/100 |
| Grade | C | C |
| Scorecard rank | #374 | #59 |
| Semaglutide | Not disclosed | $225/mo (compounded oral) |
| Tirzepatide | Not disclosed | $99/mo (starting dose, brand-name) |
| Coverage | 2 states | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #374 · C
Strengths
- Physician-led clinic with a named team — physicians, NPs and registered nurses
- Offers brand-name (Wegovy, Ozempic, Zepbound, Mounjaro) and compounded options
- No upfront payment — you start with a registered nurse consult
- Microdosing GLP-1 approach available for longer-term use
Where it loses points
- Telehealth only in Louisiana and Texas — not nationwide
- No upfront pricing published; cost depends on the plan after consult
- Compounded options prescribed only when medically appropriate
- Broader aesthetic/clinic focus, not a GLP-1-only specialist
Graded #59 · C
Strengths
- Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
- LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
- Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary
Where it loses points
- Sublingual compounded semaglutide hasn't been tested in humans, per Wisp's own page — only the injectables have FDA efficacy data
- Pharmacy partners not named
- States served not listed publicly
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.